L-asparaginase-based treatment of 15 western patients with extranodal NK/T-cell lymphoma and leukemia and a review of the literature.
about
Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases.Effectiveness of gemcitabine, pegaspargase, cisplatin, and dexamethasone (DDGP) combination chemotherapy in the treatment of relapsed/refractory extranodal NK/T cell lymphoma: a retrospective study of 17 patients.High-dose methotrexate, etoposide, dexamethasone and pegaspargase (MEDA) combination chemotherapy is effective for advanced and relapsed/refractory extranodal natural killer/T cell lymphoma: a retrospective study.Efficacy and safety of cisplatin, dexamethasone, gemcitabine and pegaspargase (DDGP) regimen in newly diagnosed, advanced-stage extranodal natural killer/T-cell lymphoma: interim analysis of a phase 4 study NCT01501149.Extranodal NK/T-cell lymphoma nasal type: efficacy of pegaspargase. Report of two patients from the United Sates and review of literature.Interobserver variation in classifying lymphomas among hematopathologists.Efficacy of gemcitabine combined with oxaliplatin, L-asparaginase and dexamethasone in patients with newly-diagnosed extranodal NK/T-cell lymphomaExtranodal natural killer/T-cell lymphoma, nasal type, involving the skin, misdiagnosed as nasosinusitis and a fungal infection: A case report and literature review.Resveratrol induces cell cycle arrest and apoptosis in malignant NK cells via JAK2/STAT3 pathway inhibitionDeciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferationsExtranodal NK/T-cell lymphoma presenting with primary cardiac involvementRadiotherapy combined with chemotherapy versus radiotherapy alone for early stage nasal natural killer/T-cell lymphoma: a meta-analysis.Global promoter methylation analysis reveals novel candidate tumor suppressor genes in natural killer cell lymphoma.Complete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma.Extranodal nasal-type NK/T-cell lymphoma of the palate and paranasal sinuses.Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma.L-asparaginase-based regimen as a first-line treatment for newly diagnosed nasal type extranodal natural killer cell/T-cell lymphomaA prospective phase II study of L-asparaginase- CHOP plus radiation in newly diagnosed extranodal NK/T-cell lymphoma, nasal type.Efficacy of combined gemcitabine, oxaliplatin and pegaspargase (P-gemox regimen) in patients with newly diagnosed advanced-stage or relapsed/refractory extranodal NK/T-cell lymphoma.Extranodal natural killer/T-cell lymphoma: current concepts in biology and treatment.Treatment outcomes of and prognostic factors for definitive radiotherapy with and without chemotherapy for Stage I/II nasal extranodal NK/T-cell lymphoma.Risk stratification in extranodal natural killer/T-cell lymphoma.The emerging role of histone deacetylase inhibitors in treating T-cell lymphomas.Diagnosis and management of natural killer-cell malignancies.Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma).Extranodal nasal type natural killer/T-cell lymphoma of testis: report of seven cases with review of literature.Diagnosis and management of rare gastrointestinal lymphomas.NK/T-cell lymphomas: pathobiology, prognosis and treatment paradigm.Current and future management of NK/T-cell lymphoma based on clinical trials.A critical review on properties and applications of microbial l-asparaginases.Clinical study of l-asparaginase in the treatment of extranodal NK/T-cell lymphoma, nasal type.Clonal deleted latent membrane protein 1 variants of Epstein-Barr virus are predominant in European extranodal NK/T lymphomas and disappear during successful treatment.Encouraging experience in the treatment of nasal type extra-nodal NK/T-cell lymphoma in a non-Asian population.Differential mechanisms of asparaginase resistance in B-type acute lymphoblastic leukemia and malignant natural killer cell linesPharmacology, immunogenicity, and efficacy of a novel pegylated recombinant Erwinia chrysanthemi-derived L-asparaginase.Primary NK/T cell lymphoma nasal type of the colon.High-dose therapy and autologous stem cell transplantation for extra-nodal NK/T lymphoma in patients from the Western hemisphere: a study from the European Society for Blood and Marrow Transplantation.Lymphoma associated hemophagocytic syndrome: it's going viral.Treatment results and prognostic factors in primary thyroid lymphoma patients: a rare cancer network study.Aggressive natural killer cell leukemia: a case report.
P2860
Q30244110-8DFD5D6A-D932-4700-B9AD-900B9559629CQ33415901-417D6D68-B4A9-40E1-A39A-C0D5BB19B20BQ33423016-4BB4C673-5B17-400B-B64C-E2F1EDFAD8B8Q33433689-BB2A9A11-7ACA-41ED-AF4B-FF51313FA353Q33620726-0B69F2A4-A815-4A35-831F-F2CE11E520A4Q34157166-98AEA068-1C52-4115-98F1-E2639C96C148Q34265725-84479C71-A895-4E64-9F0D-EED29241D941Q34293085-8C7D2C66-0A9A-4E0B-8B5F-6116B6396968Q34571639-BA9B6976-F709-405F-94C0-FDC40E8FECDCQ35232848-8D408295-22ED-4D28-9D30-DFA8921E131FQ35615351-9FED57D0-26EF-4E10-9D85-E3A475728300Q35630934-9CB101C1-8D0A-4655-93E6-DA42E7482C30Q35859357-9492BDAF-CB19-4961-80C9-B1505C370EA5Q36156508-3217F104-04F2-4FFB-94EE-E325E52D88B1Q36738758-1B6C2872-B950-4B32-8A50-4C8576AD6EDAQ36765418-7886E30C-6FBA-4761-98CE-0886C76FDDBCQ36954142-17C1D3C9-9FF4-46DB-8AD5-FA70232AACE7Q37071962-38CF5753-B1BF-4D2F-9B15-5CCF64AB32CCQ37301747-60E26989-96B8-480A-B313-8BED65A1851BQ37626051-BA27AA2E-A6E2-44E8-AA3B-37560A220E57Q37659291-6451C56D-CE07-4F23-A117-F60A834AEFEAQ37788238-2A1B8D6E-5C7E-4A9A-B097-959633065AA3Q37809805-AC34BC89-2660-4E40-AA15-2A5B2CB6E026Q37810280-15B13C66-3D48-4AC4-BF76-2AE7DD377960Q37863688-3522CD58-4F22-4973-9338-65B673901D75Q37963470-07854883-3748-4EA6-9434-BC27C2C07539Q38012167-16188031-A5B3-4CD1-AC61-C778526A9B6CQ38013696-38837C06-8C6E-4BF8-9504-00CEEAAF9A9EQ38052819-ED7AA7F5-E5FF-4822-A804-1101A9F7F2AFQ38417141-5310C720-43D3-4A31-8EAD-48BF0D4E0D2AQ38433407-84FA49A8-6D0E-4547-933F-58E2B7BC54AEQ38779524-0CB9417E-37FF-4C6D-8A9F-937898F6353EQ38835470-8A7ACB2F-01EA-48F0-BFD2-99EAAB35EE11Q38915906-611881AC-4991-4E91-B18C-29974FF91A9AQ38994917-BFA60EB9-18E9-43B0-8885-3FA194135C05Q40244269-1C976E6D-F332-4EA2-88E8-7884033FBDDCQ42146630-3F91C9CD-01BC-4A72-AFDE-AB9A55331910Q42224164-F9497ECD-560D-43A4-B828-FB3A846EEB7CQ43651431-B4D797BD-527C-4A30-9BF2-4F9EA3F2CB36Q47116410-C1FD2B9E-551E-4C77-B3C3-12D184A44B5A
P2860
L-asparaginase-based treatment of 15 western patients with extranodal NK/T-cell lymphoma and leukemia and a review of the literature.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
L-asparaginase-based treatment ...... nd a review of the literature.
@en
L-asparaginase-based treatment ...... nd a review of the literature.
@nl
type
label
L-asparaginase-based treatment ...... nd a review of the literature.
@en
L-asparaginase-based treatment ...... nd a review of the literature.
@nl
prefLabel
L-asparaginase-based treatment ...... nd a review of the literature.
@en
L-asparaginase-based treatment ...... nd a review of the literature.
@nl
P2093
P2860
P50
P356
P1433
P1476
L-asparaginase-based treatment ...... nd a review of the literature.
@en
P2093
C Larroche
C Thiéblemont
D Bordessoule
P2860
P304
P356
10.1093/ANNONC/MDN542
P577
2008-08-13T00:00:00Z